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Contribution of α2-adrenoceptors and Y1 neuropeptideY
receptors to the blunting of sympathetic vasoconstriction
induced by systemic hypoxia in the rat
Andrew M. Coney and Janice M. Marshall
Department of Physiology, The Medical School, Birmingham B15 2TT, UK
There is evidence that sympathetically evoked vasoconstriction in skeletal muscle is blunted
in systemic hypoxia, but the mechanisms underlying this phenomenon are not clear.
In Saffan-anaesthetized Wistar rats, we have studied the role of α2-adrenoceptors and
neuropeptideY (NPY) Y1 receptors in mediating vasoconstriction evoked by direct stimulation
ofthelumbarsympatheticchainbydifferentpatternsofimpulsesinnormoxia(N)andsystemic
hypoxia (H: breathing 8% O2). Patterns comprised 120 impulses delivered in bursts over a
1minperiodat40or20Hz,orcontinuouslyat2Hz.Hypoxiaattenuatedtheevokedincreasesin
femoralvascularresistance(FVR)byallpatterns,theresponseto2Hzbeingmostaffected(40Hz
bursts:N=3.25±0.75arbitraryresistanceunits(RU);H=1.14±0.29RU).Yohimbine(Yoh,
α2-adrenoceptorantagonist)orBIBP3226(Y1-receptorantagonist)didnotaffectbaselineFVR.
In normoxia, Yoh attenuated the responses evoked by high frequency bursts and 2Hz, whereas
BIBP3226 only attenuated the response to 40Hz (40Hz bursts: N+Yoh =2.1±0.59RU;
N+BIBP3226=1.9±0.4RU).Inhypoxia,Yohdidnotfurtherattenuatetheevokedresponses,
butBIBP3226furtherattenuatedtheresponseto40Hzbursts.Theseresultsindicatethatneither
α2-adrenoceptorsnorY1 receptorscontributetobasalvasculartoneinskeletalmuscle,butboth
contribute to constrictor responses evoked by high frequency bursts of sympathetic activity.
We propose that in systemic hypoxia, the α2-mediated component represents about 50% of
the sympathetically evoked constriction that is blunted, whereas the contribution made by
Y1 receptors is resistant. Thus we suggest the importance of NPY in the regulation of FVR and
blood pressure increases during challenges such as systemic hypoxia.
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The vasodilatation that occurs in skeletal muscle during
systemic hypoxia represents a balance between the
vasoconstrictor effects of increased muscle sympathetic
nerve activity (MSNA) and the dilator inﬂuences of local
mediators and circulating adrenaline (Marshall, 1994).
Thus, in the rat, α-adrenoceptor blockade enhanced the
decreaseinmusclevascularresistanceinducedbysystemic
hypoxia and dilator responses in individual skeletal
muscle arterioles, while converting arteriolar constrictor
responsestodilatorresponses(Marshall&Metcalfe,1988;
Mian & Marshall, 1991). Similarly, in human subjects
vasodilatation evoked in forearm by systemic hypoxia was
augmented by α-adrenoceptor blockade (Weisbrod et al.
2001). Such observations raise the question of whether
the vasoconstrictor inﬂuence of MSNA is blunted during
systemichypoxia,orthereissummationofconstrictorand
dilator inﬂuences and the latter dominates.
There is some evidence that vasoconstriction evoked
by increased MSNA is indeed blunted by systemic
hypoxia. Reﬂex vasoconstriction evoked in forearm by
lower body negative pressure (LBNP) was reduced by
mild and moderate systemic hypoxia (breathing 12
and 10% O2, respectively; Heistad & Wheeler, 1970).
Moreover, the increases in MSNA evoked by LBNP were
preserved during mild and moderate hypoxia, but the
forearm vasoconstrictor responses were reduced (Rowell
& Seals, 1990). However, reﬂex vasoconstriction evoked
by LBNP in muscle microcirculation, as assessed by
near infra-red spectroscopy, was well maintained during
moderate hypoxia (Hansen et al. 2000). Further, forearm
vasoconstriction evoked by tyramine, which releases
noradrenaline from sympathetic ﬁbres, was preserved
during mild and moderate hypoxia (Dinenno et al.
2003).
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Such disparities may be attributable to differences in
the levels of hypoxia and methods used to activate the
sympathetic nerves. In anaesthetized rats, we stimulated
the sympathetic chain with three different patterns that
delivered the same number of impulses over 1min (see
Coney & Marshall, 2003): continuous stimulation at 2Hz
to represent a low, resting level of MSNA and bursts of
impulses at 20 or 40Hz to represent the high frequency
bursts that occur when MSNA is raised, for example
by systemic hypoxia (Maceﬁeld et al. 1994; Johnson &
Gilbey,1996;Hudsonetal.2002).Theincreasesinfemoral
vascularresistance(FVR)evokedbyburstsat20and40Hz
were not affected by mild or moderate hypoxia, but were
considerably blunted by severe hypoxia (8% O2): that
evoked by continuous stimulation at 2Hz was blunted by
moderate, as well as severe, hypoxia (Coney & Marshall,
2003).
These blunting effects were not altered by adenosine
receptorblockade,orinhibitionofcyclooxygenaseactivity
(Coney & Marshall, 2003; Tomlinson et al. 2005), even
though the muscle vasodilatation of systemic hypoxia is
largely mediated by adenosine with prostacyclin acting as
anintermediate(Bryan&Marshall,1999;Rayetal.2002).
Further, they could not be ascribed to NO generated by
endothelial, or neuronal NOS (Coney et al. 2004), even
though the hypoxia-induced vasodilatation is largely NO
dependent (Skinner & Marshall, 1996).
In view of these ﬁndings, the question arises as to
whether systemic hypoxia inﬂuences the action of the
sympathetic cotransmitters. In vitro studies indicate that
ATP makes the major contribution to vasoconstriction
evoked in arteries by single impulses or short trains at
low frequency, while noradrenaline becomes important
whentheimpulsetrainislongerorthefrequencyincreases
(Kennedy et al. 1986; Sj¨ oblom-Widfelt & Nilsson, 1990).
Ontheotherhand,invivostudiesonrathindlimbsuggest
that ATP and noradrenaline are mutually facilitatory
in producing vasoconstriction evoked by sympathetic
stimulation with low and high frequencies (Johnson
et al. 2001). Further, in vivo studies on skeletal muscle
indicate that sympathetic stimulation at constant high
frequency, or with irregular activity containing high
frequency bursts releases neuropeptideY (NPY), while
in various arterial preparations, high frequency patterns
evoke NPY-mediated contstiction (Pernow et al. 1989;
Morris & Gibbins, 1992).
Considering these transmitters, the fact that A1 or
A2A adenosine receptor blockade had no effect on
hypoxia-induced blunting of sympathetically evoked
vasoconstriction (see above, Coney & Marshall, 2003)
indicates that it is not caused by pre- or postsynaptic
actionsofadenosineformedfromsympatheticallyreleased
ATP (Ralevic & Burnstock, 1990). Hypoxia may affect the
postsynaptic actions of ATP, but this is difﬁcult to test in
vivo in the absence of selective P2X receptor antagonists.
Severe systemic hypoxia inhibits vasoconstriction evoked
bynoradrenalineinfusioninrats(Coney&Marshall,2003)
andhumans(Heistad&Wheeler,1970).Moreover,graded
hypoxia(PO2 100–40mmHg)producedgradeddepression
ofcontractionevokedbystimulationofα1-adrenoceptors
in rat iliac and other arteries (Ebeigbe, 1982; Pearce et al.
1992; Franco-Obregon & Lopez-Barneo, 1996; Bartlett &
Marshall, 2002). However, sympathetically evoked vaso-
constriction in skeletal muscle is partly mediated by
α2-adrenoceptors (Ohyanagi et al. 1991; Dinenno et al.
2002)andα2-adrenoceptor-evokedarteriolarconstriction
is particularly vulnerable to local hypoxia (Tateishi &
Faber, 1995). Whether the α2-adrenoceptor component
of sympathetic vasoconstriction is blunted by systemic
hypoxia has not been examined. Further, there is little
pharmacological evidence on the contribution of NPY to
sympatheticallyevokedvasoconstrictioninskeletalmuscle
in vivo (see Jackson et al. 2004).
Thus, we tested the hypotheses that severe systemic
hypoxia blunts muscle vasoconstriction evoked by
sympathetic chain stimulation with high and low
frequency patterns chosen to mimic the range of MSNA
that occur at rest and during reﬂex activation, by limiting
the components that are mediated by α2-adrenoceptors
and by NPY acting on Y1 receptors, the NPY receptors
that are mainly responsible for inducing vasoconstriction
(Modin et al. 1991).
Methods
ExperimentswereperformedontwogroupsofmaleWistar
rats. All experiments were approved by UK legislation
under the Home Ofﬁce Animals (Scientiﬁc Procedures)
Act 1986. Anaesthesia was induced with halothane (3.5%
in O2) and judged to be of a surgical level when pedal
withdrawal reﬂexes were absent. A jugular vein was then
cannulated for continuous infusion of the anaesthetic
Saffan (Schering-Plough Animal Health, Welwyn Garden
City, UK) at 7–12mgkg−1 h−1. Thereafter, the level of
anaesthesia was judged to be adequate by the absence of
withdrawal reﬂexes and stability of arterial blood pressure
(ABP),aswehavepreviouslydescribed(Coney&Marshall,
2003).Attheendoftheexperimentsallanimalswerekilled
by anaesthetic overdose.
Thesurgicalpreparationoftheanimalandtherecording
techniques were essentially as we have described before
(Coney & Marshall, 2003). Brieﬂy, the trachea was
cannulatedandtheside-armofthecannulawasconnected
to a system of rotameters in a gas proportioner frame
(CP Instruments, Hanwell, London, UK), allowing the
rats to breathe either a normoxic (21% O2 in N2)o r
a hypoxic (8% O2 in N2) gas mixture, as described
below. Both brachial arteries were cannulated, one being
used to monitor arterial blood pressure (ABP), the other
allowing 150μl samples to be taken anaerobically for
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analysis by a blood gas analyser (IL1640; Instrumentation
Laboratories, Warrington, Cheshire, UK): samples were
taken in normoxia and during hypoxia following the
periodofsympatheticstimulation(seebelow).Thecaudal
ventral tail artery was retrogradely cannulated to allow
administration of drugs predominantly to the right
hindlimb from which blood ﬂow was recorded (see
below). The left femoral vein was cannulated to allow
administration of pharmacological antagonists.
Abipolar,silver-wirestimulatingelectrodewasattached
to the right lumbar sympathetic chain between L3
and L4 via a laparotomy, the great vessels being
temporarily retracted to expose the sympathetic chain.
The electrode tips were embedded in dental impression
material (President, Light Body, Colt´ ene, Switzerland) to
both mechanically ﬁx and electrically isolate them. The
electrodes were used to deliver three different patterns
of nerve stimulation at constant current via an isolated
stimulator (DS2A; Digitimer, UK). The patterns delivered
the same number of 1ms pulses at a constant current of
1mA in a 1min period (see Coney & Marshall, 2003):
(1) continuous stimulation at 2Hz, (2) a 20Hz burst for
1s repeated every 10s (bursts at 20Hz), and (3) a 40Hz
burst for 0.5s repeated every 10s (bursts at 40Hz). Each
pattern resulted in 120 impulses being delivered over the
1min stimulation period: they were delivered in random
order.
Blood ﬂow was recorded from the right femoral artery
(FBF) via a perivascular ﬂowprobe (0.7V; Transonic
Systems, Ithaca, NY, USA) connected to a ﬂowmeter
(T106; Transonic Systems). ABP and FBF were acquired
into Chart software (ADInstruments) via a MacLab/8s
(ADInstruments) at a sampling frequency of 100Hz.
Mean arterial pressure (MAP) and heart rate (HR) were
derivedon-linefromtheABPsignal,andfemoralvascular
resistance (FVR) was calculated on-line, by the division of
ABP by FBF.
Protocols
Group 1: sympathetic stimulation before and after
α2-adrenoceptor antagonism. The responses evoked by
sympathetic stimulation with bursts at 40 and 20Hz
and by continuous stimulation at 2Hz were tested in
seven rats (body mass 218±8g: mean±s.d.) during
normoxia. The inspirate was then switched to hypoxia
(8% O2) and at least 1min after a new steady baseline
had been achieved, the responses evoked by sympathetic
stimulation were re-tested. The inspirate was then
returned to normoxia and the animal allowed to
recover for at least 10–15min. The α2-adrenoceptor
antagonist yohimbine (Sigma, UK) was administered
intravenously at a dose of 0.5mgkg−1 and following
an equilibration period of 10–15min, the responses to
stimulation were re-tested under both normoxic and
hypoxic conditions. In previous studies, this dose of
yohimbinewasshowntoselectivelyandmaximallyinhibit
α2-adrenoceptor-mediated sympathoinhibition (Szabo
etal.1993).Inpilotstudiesthisdoseabolishedtheincrease
inABPevokedbyinfusionoftheα2-adrenoceptoragonist
UK14304 (A.M. Coney & J.M. Marshall, unpublished
observations).
Group 2: sympathetic stimulation before and during
infusion of an NPY Y1 receptor antagonist. Thisprotocol
was performed in seven rats (mean±s.d., body mass
213±11g). The protocol was essentially the same as
for Group1, except that when the responses to all three
patterns of sympathetic stimulation had been tested in
normoxia and during hypoxia, the animal was allowed
to recover in normoxia for at least 10–15min and then
the NPY Y1 receptor antagonist BIBP3226 (Sigma, UK)
was infused through the caudal ventral artery at a rate
of 10μgkg −1 min−1. Responses evoked in normoxia,
and in acute hypoxia were then re-tested as described
above. This regime for administration of BIBP3226 was
shown in a previous study on the rat to selectively
reduce the facilitation produced by NPY of peripheral
vasoconstrictor responses evoked by α1-adrenoceptor
stimulation (Bischoff et al. 1997). Further, in a pilot study
on four rats, we found that administration of Leu-Pro
NPY (a Y1 agonist) at 128μgkg −1 increased ABP by
32±3mmHg.Thiswascompletelyabolishedbytheabove
regime of BIBP3226 administration.
Data analysis
Alldataareexpressedasmean±s.e.m.Datawereanalysed
as described in Coney & Marshall (2003). Thus, FVR
(mmHgml−1 min) was computed on-line by the division
of ABP by FBF and the size of the constrictor response
to sympathetic stimulation was calculated by subtracting
the integral of baseline FVR calculated from the 1min
precedingthestimulus,fromtheintegralofFVRmeasured
during the 1min stimulus. The integrated constrictor
response was expressed in arbitrary resistance units (RU).
This allowed comparison between responses evoked by
different patterns of stimulation as well as between
responses evoked from different baseline values of FVR,
i.e. during normoxia and hypoxia. Differences in baseline
and in integrated FVR before and after each antagonist
were determined by repeated measures ANOVA followed
by Student–Newman–Keuls post hoc test if P <0.05.
Results
Group 1
During normoxia, stimulation of the sympathetic chain
with bursts at 40Hz and 20Hz and continuously
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at 2Hz each evoked signiﬁcant vasoconstriction in
hindlimbmuscle:integratedFVRincreasedby3.25±0.75,
3.71±1.18 and 2.72±0.83RU, respectively. Continuous
stimulation at 2Hz tended to evoke smaller responses
than bursts at 40 or 20Hz, as previously reported, even
though the same number of impulses was delivered in
each case (see Fig. 1 and Coney & Marshall, 2003). These
vasoconstrictor responses each resulted in a signiﬁcant
decrease in FBF (data not shown, see Coney & Marshall,
2003).
Switching the inspirate to 8% O2 induced the expected
fall in arterial PO2 (PaO2) with a fall in arterial PCO2
(PaCO2) and alkalosis, reﬂecting the hypoxia-induced
hyperventilation (Table1). Concomitantly, there was
a signiﬁcant fall in FVR indicating vasodilatation in
hindlimb muscle, with FBF maintained despite the fall
in ABP (Fig. 1, Table 2), as we have described before (see
Coney & Marshall, 2003 and references therein). During
hypoxia, the increase in FVR evoked by each pattern
of sympathetic stimulation was attenuated as we have
described before (Coney & Marshall, 2003), although the
effectontheresponseevokedbyburstsat20Hzjustfailed
to reach statistical signiﬁcance (P =0.0514). The increase
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Figure 1. Effects of hypoxia and yohimbine on vasoconstrictor responses evoked in the hindlimb by
different patterns of sympathetic stimulation
Left panel shows baseline values of integrated femoral vascular resistance (FVR) over 1 min recorded immediately
prior to sympathetic stimulation. Right panels indicate the responses evoked by the 3 patterns of sympathetic
stimulation and show the mean ± S.E.M. of the change in integrated FVR ( Int FVR). Labels below columns indicate
normoxia (N), hypoxia (H) and yohimbine (Yoh). Symbols indicate statistical signiﬁcance of P < 0.05 (one symbol)
and P < 0.01 (two symbols) where ∗ = versus normoxia before or after yohimbine; † = versus before yohimbine
in normoxia or hypoxia; and ‡ = versus hypoxia before yohimbine.
in FVR evoked by continuous stimulation at 2Hz was
reduced by a greater extent than those evoked by bursts
at 20 and 40Hz (by 96 versus 49% and 64%, respectively;
see Coney & Marshall, 2003; Coney et al. 2004).
Administration of the α2-antagonist yohimbine had
no effect on any of the cardiovascular baselines or
blood gas values recorded in normoxia (Tables1 and
2). Notably, baseline FVR did not change, suggesting
no net role for α2-adrenoceptors in the maintenance of
vascular tone in hindlimb (see Discussion). However,
yohimbine signiﬁcantly attenuated the vasoconstrictor
responsesevokedinnormoxiabysympatheticstimulation
with bursts at 20Hz and 40Hz, but not that evoked by
continuous stimulation at 2Hz.
When the inspirate was switched to 8% O2, the blood
gasvaluesweresimilartothoserecordedinhypoxiabefore
yohimbine (Table 1). Further, baseline ABP and FVR fell
signiﬁcantly to similar levels to those recorded in hypoxia
beforeyohimbine(Table2,Fig.1).Undertheseconditions,
the increases in FVR evoked by sympathetic stimulation
with all three patterns were attenuated compared to
those evoked in normoxia after yohimbine (Fig. 1). This
did not reach statistical signiﬁcance for the response
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Table 1. Arterial blood gas and pH values in all groups in different conditions
PaO2 PaCO2
(mmHg) (mmHg) pH
Group 1 Normoxia 81.9 ± 3.2 38.4 ± 1.4 7.422 ± 0.013
Hypoxia 27.9 ± 1.0∗∗∗ 22.9 ± 1.3∗∗∗ 7.542 ± 0.014∗∗∗
Normoxia + yohimbine 93.3 ± 4.0 36.4 ± 2.2 7.428 ± 0.014
Hypoxia + yohimbine 32.0 ± 1.8∗∗∗ 23.7 ± 1.8∗∗∗ 7.496 ± 0.035
Group 2 Normoxia 86.3 ± 4.1 39.3 ± 1.8 7.367 ± 0.023
Hypoxia 34 ± 1.3∗∗∗ 27.6 ± 1.1∗∗∗ 7.451 ± 0.015∗∗∗
Normoxia + BIBP 3226 88.2 ± 3.1 38.2 ± 2.1 7.372 ± 0.031
Hypoxia + BIBP 3226 33.7 ± 1.6∗∗∗ 28.1 ± 1.3∗∗∗ 7.446 ± 0.012∗∗∗
Values are mean ± S.E.M. Normoxia (air breathing) and hypoxia (breathing 8% O2) in the absence
or presence of either yohimbine or BIBP 3226. Asterisks indicate statistical signiﬁcance of P < 0.001
(∗∗∗) compared to normoxia.
Table 2. Baseline cardiovascular variables in all groups in different conditions
FVR
ABP HR FBF (mmHg
(mmHg) (beats min−1) (ml min−1)m l −1 min)
Group 1 Normoxia 106 ± 5 419 ± 19 1.26 ± 0.08 85.7 ± 6.1
Hypoxia 58 ± 6∗∗ 407 ± 35 1.11 ± 0.20 57.8 ± 6.7∗
Normoxia + yohimbine 100 ± 4 442 ± 17 1.25 ± 0.30 103.6 ± 18.6
Hypoxia + yohimbine 62 ± 6∗∗ 429 ± 29 1.24 ± 0.32 63.0 ± 10.6∗∗
Group 2 Normoxia 125 ± 5 451 ± 16 2.16 ± 0.37 69.6 ± 10.2
Hypoxia 74 ± 4∗∗∗ 488 ± 36 1.83 ± 0.18 42.4 ± 3.7∗
Normoxia + BIBP 3226 123 ± 6 481 ± 18 2.11 ± 0.18 61.6 ± 5.8
Hypoxia + BIBP 3226 77 ± 5∗∗ 502 ± 24 2.22 ± 0.33 38.3 ± 4.2∗∗
Values are mean ± S.E.M. Normoxia (air breathing) and hypoxia (breathing 8% O2) in the absence or presence of
either yohimbine or BIBP 3226. Asterisks indicate statistical signiﬁcance of P < 0.05 (∗), P < 0.01 (∗∗) and P < 0.001
(∗∗∗) compared to normoxia. ABP, arterial blood pressure; HR, heart rate; FBF, femoral blood ﬂow; FVR, femoral
vascular resistance.
to 20Hz (P =0.1) probably reﬂecting the variability of
the responses evoked by bursts at 20Hz in normoxia
(see Fig. 1). Nevertheless the results indicated that
yohimbinedidnotpreventanattenuatingeffectofhypoxia
on the sympathetically evoked vasoconstrictor responses.
Therewerenosigniﬁcantdifferencesbetweentheincrease
in FVR evoked by sympathetic stimulation in hypoxia
after yohimbine compared to those evoked in hypoxia
before yohimbine, i.e. hypoxia reduced the constrictor
responses to the same levels before and after yohimbine
(Fig. 1). On the other hand, the increases in FVR evoked
by bursts at 40Hz and continuous stimulation at 2Hz in
normoxia after yohimbine were signiﬁcantly greater than
those evoked during hypoxia before yohimbine (Fig. 1).
In other words, hypoxia attenuated these vasoconstrictor
responses to a greater extent than yohimbine.
Group 2
Thebloodgasvaluesandbaselinecardiovascularvariables
recorded during normoxia were similar to those of
Group1 (Tables1 and 2). In normoxia, stimulation of the
sympathetic chain with all three patterns of stimulation
evoked increases in FVR that were similar to those evoked
in Group1. Moreover these responses were attenuated
during hypoxia as in Group1 (Fig. 3 cf. Fig. 1). Typical
responses evoked by bursts at 40Hz under the different
experimental conditions are shown in Fig. 2.
Infusion of the Y1 antagonist BIBP3226 had no effect
on the blood gas values or cardiovascular baselines (see
Tables1 and 2, Fig. 3). The constrictor responses evoked
by the different patterns of sympathetic stimulation in
normoxia were differentially affected by BIBP3226. Thus,
the increase in FVR evoked by bursts at 40Hz was
attenuated, while the increase in FVR evoked by bursts
at 20Hz and by continuous stimulation at 2Hz was not
different from that evoked before BIBP3226 (Fig. 3).
Infusion of BIBP3226 had no effect on the
hypoxia-induced changes in blood gases, nor on the fall
in baseline ABP and FVR (Tables1 and 2, Fig. 3). Further,
in the presence of BIBP3226, hypoxia still reduced the
increase in FVR evoked by each pattern of sympathetic
stimulation (Fig. 3). However, the increase in FVR evoked
by bursts at 40Hz reached a lower level in hypoxia during
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Figure 2. Original recordings of responses evoked by the 40 Hz bursting pattern of sympathetic nerve
stimulation during air breathing and systemic hypoxia in the absence and presence of the NPY
antagonist BIBP 3226
The periods of stimulation are indicated by bars under each response whilst the infusion of BIBP 3226 is indicated
by the bar under the right panels. ABP, arterial blood pressure; FBF, femoral blood ﬂow; FVR, femoral vascular
resistance.
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Figure 3. Effects of hypoxia and BIBP 3226 on vasoconstrictor responses evoked in the hindlimb by
different patterns of sympathetic stimulation
Left panel shows baseline values of integrated FVR over 1 min recorded immediately prior to sympathetic
stimulation. Right panels indicate the responses evoked by the 3 patterns of sympathetic stimulation and show
the mean ± S.E.M. of the change in integrated FVR ( Int FVR). Labels below the columns indicate normoxia (N),
hypoxia (H) and BIBP 3226 (BIBP). Symbols indicate statistical signiﬁcance of P < 0.05 (one symbol) and P < 0.01
(two symbols) where ∗ = versus normoxia; † = versus before BIBP 3226 in normoxia or hypoxia.
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BIBP3226infusionthanitdidinhypoxiabeforeBIBP3226
(Fig.3).TherewasatrendforasimilareffectofBIBP3226
on the increase in FVR evoked in hypoxia by bursts at
20Hz although this failed to reach statistical signiﬁcance
(P =0.101). On the other hand the increase in FVR
evoked by continuous stimulation at 2Hz in hypoxia
during BIBP3226 infusion was similar to that evoked in
hypoxia before the antagonist (Fig. 3).
Discussion
The present study conﬁrmed that severe systemic hypo-
xia attenuates the increase in FVR evoked in the hind-
limb by each of three different patterns of sympathetic
stimulation: continuous stimulation at 2Hz and bursts at
20 and 40Hz (see Coney & Marshall, 2003; Coney et al.
2004).Thenewﬁndingswere(i)thattheα2-adrenoceptor
antagonist yohimbine had no effect on baseline FVR, but
(ii)reducedtheincreasesinFVRevokedbyhighfrequency
burstsofsympatheticstimulationinnormoxia,whilst(iii)
havingnoeffectontheattenuationoftheresponsesevoked
by any of the three patterns of stimulation in hypoxia. On
the other hand (iv) the Y1 receptor antagonist BIBP3226
hadnoeffectonbaselineFVR,but(v)reducedtheincrease
in FVR evoked in normoxia by high frequency bursts, and
(vi) in hypoxia, these responses were reduced to a greater
extent than they were in the absence of this antagonist.
Role of α2-adrenoceptors in hindlimb
A substantial component of the vasoconstrictor tone
in rat hindlimb under conditions comparable to the
normoxic condition of the present study is dependent
on α-adrenoceptor stimulation (Johnson et al. 2001), in
common with other studies on limb muscle (e.g. Kiowski
et al. 1983; Jie et al. 1987; Taddei et al. 1988; Dinenno
et al. 2002). Our new ﬁnding that the α2-adrenoceptor
antagonistyohimbinehadnoeffectonbaselineFVRunder
normoxic conditions indicates that α2-adrenoceptor
stimulation makes no overall contribution to resting
tone in rat limb muscle in Saffan-anaesthetized
rats. This may be because the noradrenaline that is
tonically released from the sympathetic varicosities
exerts a minimal vasoconstrictor effect by stimulating
postjunctional α2- a d r e n o c e p t o r s .H o w e v e r ,i tm a y
also be that the inhibitory effect of yohimbine on
postjunctional α2-adrenoceptors is offset by its inhibitory
effect on prejunctional α2-adrenoceptors whose
stimulation inhibits noradrenaline release (Ruffolo et al.
1991). Another possibility concerns the location of
the postjunctional receptors. Studies on the cremaster
muscle of the rat, showed that the distal arterioles
have α2- but not α1-adrenoceptors and constrictor
responses evoked by sympathetic nerve stimulation
were mediated entirely by α2-adrenoceptors; proximal
arterioles have α1- and α2-adrenoceptors, but their
responses to sympathetic stimulation were mediated by
α1-adrenoceptors (Faber, 1988; Ohyanagi et al. 1991).
Thus, if innervated α2-adrenoceptors are predominantly
located on the distal arterioles of hindlimb muscle, it
could be that tonically released noradrenaline constricts
these arterioles, but removal of this inﬂuence has little
effect on gross vascular resistance i.e. FVR.
In human forearm, an α2-adrenoceptor antagonist,
whether given alone, or after an α1-adrenoceptor
antagonist, suggested that α2-adrenoceptor stimulation is
responsiblefor50–60%ofrestingvasculartone(Dinenno
et al. 2002). This apparent disparity between rat and
human may reﬂect differences in the relative importance
of pre- and postjunctional α2-adrenoceptors and/or in
the contribution of the resistance of distal arterioles to
gross vascular resistance. Alternatively, the patterning of
MSNAmaybedifferentinrestinghumansubjectsandrats
under Saffan anaesthesia and may inﬂuence the relative
importance of α2-adrenoceptors.
That yohimbine reduced the increase in FVR evoked
by sympathetic stimulation with high frequency bursts
by ∼25–30% is consistent with this possibility. Assuming
the innervated α2-adrenoceptors are located on the distal
arterioles,ourﬁndingsindicatethatduringhighfrequency
bursts, noradrenaline causes substantial constriction of
distal arterioles by stimulating α2-adrenoceptors and this
exerts a substantial inﬂuence on FVR. Thus, it may be
that the MSNA in the resting human subjects studied by
Dinenno et al. (2002) was of a higher average frequency,
or contained more high frequency bursts than in the
Saffan-anaesthetized rat.
In a previous study on pithed rats with consequent
low ABP, in which hindlimb muscle was perfused at
constantﬂow,theincreasesinFVRevokedbysympathetic
stimulation at frequencies of 2–4Hz were potentiated
by α2-adrenoceptor blockade, whereas those evoked by
stimulation at higher frequencies up to 100Hz were not
affected(Medgett&Ruffolo,1988).Theseresultssuggested
a preferential inﬂuence of presynaptic α2-adrenoceptor
stimulationatlowfrequencies,butrevealednoconstrictor
roleforpostsynapticα2-adrenoceptorsatanyfrequency.It
seems reasonable to suggest that the results of the present
study on anaesthetized rats with an intact central nervous
system supersede these earlier ﬁndings. Our ﬁnding that
the depressive effect of yohimbine on the increase in FVR
evoked by continuous stimulation at 2Hz failed to reach
statisticalsigniﬁcance,mayreﬂecttheopposinginﬂuences
of pre- and postsynaptic α2-adrenoceptor stimulation
on this response. However, our ﬁndings on the effect
of yohimbine on increases in FVR evoked by bursts
add to the evidence that stimulation of postjunctional
α2-adrenoceptors contributes to sympathetically evoked
increases in muscle vascular resistance in humans (Bolli
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etal.1983;Jieetal.1984;Taddeietal.1988),catsanddogs
(Gardiner & Peters, 1982; Elsner et al. 1984).
Turning to systemic hypoxia, yohimbine had no
effect on the hypoxia-induced fall in FVR. Moreover,
in the presence of α2-adrenoceptor blockade, hypoxia
still reduced the increases in FVR evoked by all three
patterns of sympathetic stimulation relative to those
evoked in normoxia, such that the remaining responses
were comparable to those evoked in hypoxia in the
absence of α2-adrenoceptor blockade (to ∼65, 50 and
15% of the control response for bursts at 40 and 20Hz
and continuous stimulation at 2Hz, respectively). This
ﬁnding clearly indicates that systemic hypoxia blunts a
componentofsympatheticvasoconstrictioninmusclethat
is not mediated by α2-adrenoceptors. This may include
the component mediated by α1-adrenoceptors, given this
was blunted in rat iliac artery when PO2 was reduced
below 70mmHg (Bartlett & Marshall, 2002). However,
our new ﬁnding also suggests that a substantial part of
thebluntingeffectofsystemichypoxiaonsympathetically
evoked vasoconstriction is attributable to blunting of the
α2-adrenoceptor-induced component in distal arterioles.
If this were not the case, the vasodilatation induced by
hypoxia per se would have been expected to be potentiated
afteryohimbine,forsystemichypoxiaincreasestheaverage
frequency of MSNA beyond 2Hz and contains bursts
of up to 50Hz (Hudson et al. 2002). Moreover, the
increases in FVR evoked by sympathetic stimulation in
hypoxia would have been expected to be smaller than
thoseevokedinhypoxiaintheabsenceofα2-adrenoceptor
blockade. In fact, the data suggest that blunting of
the α2-adrenoceptor component explains ∼50% of the
full effect of systemic hypoxia on the responses evoked
by high frequency bursts and ∼30% of that evoked
by continuous stimulation at 2Hz (see Fig.1). Clearly,
this proposal contrasts with the conclusion of Dinenno
et al. (2003) that systemic hypoxia does not blunt either
the α1-o rα2-adrenoceptor component of sympathetic
vasoconstriction in human forearm. This disparity may
be explained by the fact that the level of systemic hypoxia
achieved in the present study was more severe (PaO2 35
versus 28mmHg),orbythefactthatDinennoetal.(2003)
stimulated the sympathetic ﬁbres pharmacologically with
tyraminewhichselectivelyreleasesnoradrenalinefromthe
varicosities:theeffectofnoradrenalineonitspostsynaptic
receptors may be very different to when electrical or
reﬂexactivationofthesympatheticﬁbresreleasesallthree
cotransmitters.
There is substantial evidence that the α2-adrenoceptor
component of vasoconstriction is vulnerable to local
factors. Thus, α2-mediated vasoconstriction of terminal
arterioles in skeletal muscle in vivo was reported to
be very sensitive to inhibition by acidosis and to
reduced O2 delivery (McGillivray-Anderson & Faber,
1990; Muldowney & Faber, 1991), while α2-mediated
constrictionofmusclearteriolesinvitrowasattenuatedby
severe hypoxia (PO2: 10mmHg, Tateishi & Faber, 1995).
Further, the increase in vascular resistance evoked by
infusion of an α2-adrenoceptor agonist in rat hindlimb
was inhibited during muscle contraction (Thomas et al.
1994). Ours is the ﬁrst study to indicate that α2-mediated
vasoconstriction evoked by sympathetic nerve activity is
blunted by systemic hypoxia.
The blunting of the α2-mediated constriction by
hypoxia in muscle arterioles in vitro, and that caused by
muscle contraction in vivo, has been attributed to the
opening of ATP-sensitive K+ (KATP) channels on vascular
smooth muscle (Tateishi & Faber, 1995; Thomas et al.
1997): KATP channel opening may impair α2-mediated
inﬂux of Ca2+ through voltage-sensitive Ca2+ channels
(Ruffulo et al. 1991). We previously provided evidence
that the opening of KATP channels, probably caused by
locallyreleasedadenosine,contributestothemusclevaso-
dilatationofsystemichypoxia(Marshalletal.1993).Thus,
it is reasonable to propose that the opening of KATP
channels underlies the blunting of the α2 component of
sympathetic vasoconstriction in systemic hypoxia.
Role of NPY
That the selective NPY Y1 receptor antagonist BIBP3226
had no effect on baseline FVR or ABP in normoxia
indicates that NPY acting on Y1 receptors plays no
signiﬁcant role in maintaining resting vascular tone in
hindlimb, or ABP in Saffan-anaesthetized rats. This is
consistent with evidence that NPY does not contribute
to maintenance of resting ABP in normotensive rats, or
humans (Michel & Rascher, 1995; Zhao et al. 1997).
In contrast with these ﬁndings, Jackson et al. (2004)
reported that BIBP3226 caused an increase in baseline
vascular conductance of hindlimb of anaesthetized rats
that was equivalent to that induced by α1-adrenoceptor
blockade, implying a major role for NPY in determining
basal vascular tone. The discrepancy with the present
results might be attributed to the fact that Jackson
et al. (2004) used Sprague–Dawley rats whereas we used
Wistars.However,itseemsmorelikelythattheexplanation
lies in the status of the cardiovascular system and this
may, in turn, reﬂect the anaesthetic regime: Jackson et al.
(2004) used barbiturate whereas we used the steroid
anaesthetic Saffan (alphaxalone–alphadalone). The rats
used by Jackson et al. (2004) were larger than those of the
present study (256–426g versus 218 and 213g in Groups
1 and 2, respectively) and baseline levels of ABP were
similar(103–106versus 106and125mmHg,respectively),
and yet baseline FBF was considerably lower in the study
of Jackson et al. (2004): ∼0.028–0.018 versus 1.26 and
2.16mlmin−1 in Groups 1 and 2, respectively. Certainly,
recent evidence indicates that barbiturate anaesthesia
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induces a sympathetically mediated increase in hind-
limb vascular resistance (Teranishi et al. 2000). This
would be consistent with a higher average frequency
of MSNA and/or more high frequency bursts under
the baseline conditions of Jackson et al. (2004). If this
were the case, their results would be consistent with
the evidence that NPY becomes important as a vaso-
constrictor in skeletal muscle and other vasculature when
thefrequencyofsympatheticnerveactivityishigh(Pernow
et al. 1989; Morris & Gibbins, 1992; Lundberg et al.
1994).
In further accord with this concept, BIBP3226 reduced
the increase in FVR evoked in normoxia by bursts at
40Hz by ∼20%, tended to reduce that evoked by bursts
at 20Hz, but had no effect on the increase in FVR evoked
by continuous stimulation at 2Hz. This ﬁnding clearly
agrees with evidence that exogenous NPY can produce
vasoconstriction in cat and human skeletal muscle
vasculature by stimulating Y1 receptors (Pernow &
Lundberg,1986;Pernowetal.1987)andthatNPYreleased
by sympathetic stimulation evokes constriction in pig
skeletal muscle by stimulating Y1 receptors (Lundberg &
Modin, 1995). Studies on cat hindlimb muscle, involving
intravascular pressure measurements at different levels of
the vascular tree and on rat cremaster muscle by intravital
microscopy, indicated that infused or topically applied
NPY, respectively, evoked constriction of proximal and
distal arterioles (Joshua, 1991; Ekelund & Erlinge, 1997).
There has been no comparable study of the site(s) of
action of NPY released from the sympathetic varicosities.
Thus, the contribution of NPY we have identiﬁed in
sympatheticallyevokedincreasesinFVRinnormoxiamay
have reﬂected constrictor inﬂuences on proximal and/or
distal arterioles.
Since in the presence of Y1 receptor blockade, systemic
hypoxia still caused a further reduction in the increase
in FVR evoked by high frequency bursts and continuous
low frequency stimulation, this conﬁrms that hypoxia
blunts the non-NPY-mediated component of the
vasoconstriction. However, the fact that in hypoxia, the
increase in FVR evoked by bursts at 40Hz was smaller
in the presence of BIBP3226 than in its absence, allows
the novel proposal that the NPY-mediated component
of this response is resistant even to the severe level
of systemic hypoxia used in the present study. Since
we have argued above that the constriction of distal
arterioles that is evoked by high frequency bursts is
mediated by α2-adrenoceptors and is blunted by systemic
hypoxia, it seems likely that it was the NPY-induced
constriction of the proximal arterioles that was resistant
to the effects of hypoxia. However, it has to be
acknowledged that our results may not fully describe the
actions of NPY since it is possible that it may also act
prejunctionally on Y2 receptors to inhibit neuro-
transmitter release.
Interactions between cotransmitters and functional
implications
It is well established that the sympathetic cotransmitters
facilitate the actions of one another (Ralevic & Burnstock,
1990; Morris & Gibbins, 1992). In accord with this, we
recentlyshowedthatblockadeofα1-andα2-adrenoceptors
with phentolamine virtually abolished the increases
in FVR evoked by a range of different patterns of
sympathetic stimulation, while desensitization of the
P2×1 purinergic receptors with αβ-methylene-ATP
reduced these responses by as much as 40–60% (Johnson
et al. 2001). Further, there is in vitro evidence that
NPY given exogenously or released by sympathetic
nerve stimulation facilitates the constrictor inﬂuence
of both noradrenaline and ATP (Morris & Gibbins,
1992; Racchi et al. 1999). Thus, the inhibitory effects
of yohimbine and BIBP3226 on the increase in FVR
evoked by high frequency bursts in normoxia cannot
be taken to simply indicate the direct contributions
of α2-adrenoceptor and Y1 receptor stimulation to
these responses: either receptor antagonist may remove
both the direct constrictor action of that receptor and
the facilitatory inﬂuence of its stimulation on the
response evoked by another transmitter. It is possible
that yohimbine not only inhibited the α2-adrenoceptor
component of distal arteriolar constriction, but also any
constriction induced in these and proximal arterioles
by nerve-released noradrenaline and/or ATP acting on
α1-adrenoceptorsandP2Xreceptors,respectively.Further,
BIBP3226 is likely to have inhibited the facilitatory
inﬂuence of NPY on constriction evoked in proximal and
distal arterioles by nerve-released noradrenaline acting
on α1- and α2-adrenoceptors and by ATP acting on P2X
receptors.
The fact that the effects of these two antagonists
were differentially affected by severe systemic hypoxia
allows important functional proposals. Thus, it seems
likely that α2-adrenoceptor constriction of distal
arterioles induced directly, or indirectly, by the high
frequency bursts of sympathetic activity induced by
systemic hypoxia per se and by additional inputs to the
central nervous system, is blunted during severe systemic
hypoxia. This would help to maximize the dilatation of
distal arterioles caused by locally released adenosine and
NO and accords with direct and indirect evidence that
dilatation of distal arterioles of skeletal muscle during
systemichypoxiafacilitatesthedistributionoftheavailable
O2 to the capillary network and allows muscle O2
consumption to be maintained (Mian & Marshall, 1991;
Edmunds & Marshall, 2001a,b). On the other hand, if
the direct and indirect inﬂuence of the NPY released
by high frequency bursts of sympathetic activity on the
proximal arterioles of muscle is preserved during severe
systemic hypoxia, this would allow some sympathetic
controloverthevascularresistanceofskeletalmuscletobe
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retained. Indeed, in severe systemic hypoxia, as in sepsis,
haemorrhage and cold stress (Zukowska-Grojec & Vaz,
1988; Qureshi et al. 1998), sympathetically released NPY
mayprovideacrucialmeansofregulatingmusclevascular
resistance and therefore ABP.
References
Bartlett IS & Marshall JM (2002). Analysis of the effects of
graded levels of hypoxia on noradrenaline-evoked
contraction in the rat iliac artery in vitro. Exp Physiol 87,
171–184.
Bischoff A, Freund A & Michel MC (1997). The Y-1 antagonist
BIBP 3226 inhibits potentiation of methoxamine-induced
vasoconstriction by neuropeptide Y. Naunyn-Schmiedebergs
Arch Pharmacol 356, 635–640.
Bolli P, Erne P, Kiowski W, Ji BH, Block LH & Buhler FR
(1983). Adrenaline-induced α2 adrenoceptor mediated
vasoconstrictor response in normotensive subjects and in
patients with essential hypertension. Clin Res 31, A843.
Bryan PT & Marshall JM (1999). Adenosine receptor subtypes
and vasodilatation in rat skeletal muscle during systemic
hypoxia: a role for A1 receptors. J Physiol 514, 151–162.
Coney AM, Bishay M & Marshall JM (2004). Inﬂuence of
endogenous nitric oxide on sympathetic vasoconstriction in
normoxia, acute and chronic hypoxia in the rat. J Physiol
555, 793–804.
Coney AM & Marshall JM (2003). Contribution of adenosine
to the depression of sympathetically evoked vasoconstriction
induced by systemic hypoxia in the rat. J Physiol 549,
613–623.
Dinenno FA, Eisenach JH, Dietz NM & Joyner MJ (2002).
Post-junctional α-adrenoceptors and basal limb vascular
tone in healthy men. J Physiol 540, 1103–1110.
Dinenno FA, Joyner MJ & Halliwill JR (2003). Failure of
systemic hypoxia to blunt α-adrenergic vasoconstriction in
human forearm. J Physiol 549, 985–994.
Ebeigbe AB (1982). Inﬂuence of hypoxia on contraction and
calcium uptake in rabbit aorta. Experimentia 38, 935–937.
Edmunds NJ & Marshall JM (2001a). Vasodilatation, oxygen
delivery and oxygen consumption in rat hindlimb during
systemic hypoxia: roles of nitric oxide. J Physiol 532,
251–259.
Edmunds NJ & Marshall JM (2001b). Oxygen delivery and
oxygen consumption in rat hindlimb during systemic
hypoxia: role of adenosine. J Physiol 536, 927–935.
E k el u n dU&E rlinge D (1997). In vivo receptor characterization
of neuropeptide Y-induced effects in consecutive vascular
sections of cat skeletal muscle. Br J Pharmacol 120, 387–392.
Elsner D, Saeed M, Sommer O, Holtz J & Bassenge E (1984).
Sympathetic vasoconstriction sensitive to α2-adrenergic
receptor blockade – no evidence for preferential innervation
of α1-adrenergic receptors in the canine femoral bed.
Hypertension 6, 915–925.
Faber JE (1988). In situ analysis of α-adrenoceptors on
arteriolar and venular smooth muscle in rat skeletal muscle
microcirculation. Circ Res 62, 37–50.
Franco-Obregon A & Lopez-Barneo J (1996). Low PO2 inhibits
calcium channel activity in arterial smooth muscle cells. Am
J Physiol Heart Circ Physiol 271, H2290–H2299.
Gardiner JC & Peters CJ (1982). Postsynaptic α1-adrenoceptor
and α2-adrenoceptor involvement in the vascular responses
to neuronally released and exogenous noradrenaline in the
hindlimb of the dog and cat. Eur J Pharmacol 84, 189–198.
Hansen J, Sander M, Hald CF, Victor RG & Thomas GD
(2000). Metabolic modulation of sympathetic
vasoconstriction in human skeletal muscle: role of tissue
hypoxia. J Physiol 527, 387–396.
Heistad DD & Wheeler RC (1970). Effect of acute hypoxia on
vascular responsiveness in man. J Clin Invest 49, 1252–1263.
Hudson S, Johnson CD, Coney AM & Marshall JM (2002).
Changes in sympathetic nerve activity recorded from skeletal
muscle arteries of the anaesthetized rat during graded levels
of systemic hypoxia. J Physiol 544.P,2 8 P.
Jackson DN, Noble EG & Shoemaker JK (2004). Y1- and
α1-receptor control of basal hindlimb vascular tone.
Am J Physiol Regul Integr Comp Physiol 287, R228–R233.
Jie K, Vanbrummelen P, Vermey P, Timmermans PBMWM &
Vanzwieten PA (1984). Identiﬁcation of vascular
postsynaptic α1-adrenoceptors and α2-adrenoceptors in
man. Circ Res 54, 447–452.
Jie K, Vanbrummelen P, Vermey P, Timmermans PBMWM &
Vanzwieten PA (1987). Postsynaptic α1-adrenoceptor and
α2-adrenoceptor in human blood vessels – interactions with
exogenous and endogenous catecholamines. Eur J Clin Invest
17, 174–181.
Johnson CD, Coney AM & Marshall JM (2001). Roles of
norepinephrine and ATP in sympathetically evoked
vasoconstriction in rat tail and hindlimb in vivo. Am J
Physiol Heart Circ Physiol 281, H2432–H2440.
Johnson CD & Gilbey MP (1996). On the dominant rhythm in
the discharges of single postganglionic sympathetic neurons
innervating the rat tail artery. J Physiol 497, 241–259.
Joshua IG (1991). Neuropeptide Y-induced constriction in
small resistance vessels of skeletal muscle. Peptides 12, 37–41.
Kennedy C, Saville VL & Burnstock G (1986). The
contributions of noradrenaline and ATP to the responses of
the rabbit ear artery to sympathetic nerve stimulation
depend on the parameters of stimulation. Eur J Pharmacol
122, 291–300.
Kiowski W, Hulthen UL, RitzR&B uhler FR (1983).
α2-Adrenoceptor-mediated vasoconstriction of arteries. Clin
Pharmacol Ther 34, 565–569.
Lundberg JM, Franco-Cereceda A, Lou YP, ModinA&P e r n o w
J (1994). Differential release of classical transmitters and
peptides. Adv Second Messenger Phosphoprotein Res 29,
223–234.
Lundberg JM & Modin A (1995). Inhibition of sympathetic
vasoconstriction in pigs in vivo by the neuropeptide Y
Y1 receptor antagonist BIBP3226. Br J Pharmacol 116,
2971–2982.
Maceﬁeld VG, Wallin BG & Vallbo AB (1994). The discharge
behaviour of single vasoconstrictor motoneurons in human
muscle nerves. J Physiol 481, 799–809.
McGillivray-Anderson KM & Faber JE (1990). Effect of
r e d u c e db l o o dﬂ o wo nα1-adrenoceptor and
α2-adrenoceptor constriction of rat skeletal-muscle
microvessels. Circ Res 69, 165–173.
Marshall JM (1994). Peripheral chemoreceptors and
cardiovascular regulation. Physiol Rev 74, 543–594.
C   2007 The Authors. Journal compilation C   2007 The Physiological SocietyJ Physiol 582.3 Sympathetic vasoconstriction in systemic hypoxia 1359
Marshall JM & Metcalfe JD (1988). Analysis of the
cardiovascular changes induced in the rat by graded levels of
systemic hypoxia. J Physiol 407, 385–403.
Marshall JM, ThomasT&T u r n e rL(1993). A link between
adenosine, ATP-sensitive K+ channels, potassium and
muscle vasodilatation in the rat in systemic hypoxia. J Physiol
472, 1–9.
Medgett IC & Ruffolo RR (1988). α2-Adrenoceptor-mediated
vasoconstriction in rat hindlimb – innervated α2
adrenoceptors in the saphenous arterial bed. J Pharmacol
Exp Ther 246, 249–254.
M i a nR&M a r shall JM (1991). The roles of catecholamines in
responses evoked in arterioles and venules of rat skeletal
muscle by systemic hypoxia. J Physiol 436, 499–510.
Michel MC & Rascher W (1995). Neuropeptide Y – a possible
role in hypertension. JH y p e rt e n s13, 385–395.
M o d i nA ,P e r n o wJ&L undberg JM (1991). Evidence for two
neuropeptide Y receptors mediating vasoconstriction.
Eur J Pharmacol 203, 165–171.
Morris JL & Gibbins IL (1992). Co-transmission and
neuromodulation. In Autonomic Neuroeffector Mechanisms,
ed. Burnstock G & Hoyle CHV, pp. 33–119. Harwood, Chur,
Switzerland.
Muldowney SM & Faber JE (1991). Preservation of venular but
not arteriolar smooth muscle α-adrenoceptor sensitivity
during reduced blood ﬂow. Circ Res 69, 1215–1225.
Ohyanagi M, Faber JE & Nishigaki K (1991). Differential
activation of α1- and α2-adrenoceptors on microvascular
smooth muscle during sympathetic nerve stimulation. Circ
Res 68, 232–244.
Pearce WJ, Ashwal S, Long DM & Cuevas J (1992). Hypoxia
inhibits calcium inﬂux in rabbit basilar and carotid arteries.
Am J Physiol Heart Circ Physiol 262, H106–H113.
P e r n o wJ&L undberg JM (1986). Neuropeptide-Y constricts
human skeletal muscle arteries via a nifedipine-sensitive
mechanism independent of extracellular calcium. Acta
Physiol Scand 128, 655–656.
Pernow J, Ohlen A, Hokfelt T, Nilsson O & Lundberg JM
(1987). Neuropeptide Y – presence in perivascular
noradrenergic neurons and vasoconstrictor effects on
skeletal muscle blood vessels in experimental animals and
man. Regul Pept 19, 313–324.
Pernow J, Schwieler J, Kahan T, Hjemdhal P, Oberle J, Wallin
BG & Lundberg JM (1989). Inﬂuence of sympathetic nerve
discharge pattern on norepinephrine and neuropeptide
Y-release. Am J Physiol Heart Circ Physiol 257,
H866–H872.
Qureshi NU, Dayao EK, Shirali S, Zukowska-Grojec Z &
Hauser GJ (1998). Endogenous neuropeptide Y mediates
vasoconstriction during endotoxic and hemorrhagic shock.
Regul Pept 75–76, 215–220.
Racchi H, Irarrazabal MJ, Howard M, Moran S, Zalaquett R &
Huidobro-Toro JP (1999). Adenosine 5 -triphosphate and
neuropeptide Y are co-transmitters in conjunction with
noradrenaline in the human saphenous vein. Br J Pharmacol
126, 1175–1185.
Ralevic V & Burnstock G (1990). Postjunctional synergism of
noradrenaline and adenosine 5 -triphosphate in the
mesenteric arterial bed of the rat. Eur J Pharmacol 175,
291–299.
Ray CJ, Abbas MR, Coney AM & Marshall JM (2002).
Interactions of adenosine, prostaglandins and nitric oxide in
hypoxia-induced vasodilatation: in vivo and in vitro studies.
J Physiol 544, 195–209.
Rowell LB & Seals DR (1990). Sympathetic activity during
graded central hypovolemia in hypoxemic humans. Am J
Physiol Heart Circ Physiol 259, H1197–H1206.
Ruffolo RR, Nichols AJ, Stadel JM & Hieble JP (1991).
Structure and function of α-adrenoceptors. Pharmacol Rev
43, 475–505.
Sj¨ oblom-Widfeldt N, Gustafsson H & Nilsson H (1990).
Transmitter characteristics from small mesenteric arteries in
the rat. Acta Physiol Scand 138, 203–212.
Skinner MR & Marshall JM (1996). Studies on the roles of ATP,
adenosine and nitric oxide in mediating muscle
vasodilatation induced in the rat by acute systemic hypoxia.
J Physiol 495, 553–560.
Szabo B, Urban R & Starke K (1993). Sympathoinhibition by
rilmenidine in conscious rabbits – involvement of
α2-adrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol
348, 593–600.
Taddei S, Salvetti A & Pedrinelli R (1988). Further evidence for
the existence of α2-mediated adrenergic vasoconstriction in
human vessels. Eur J Clin Pharmacol 34, 407–410.
T a t e i s h iJ&F a b e rJ E(1995). Inhibition of arteriole
α2-adrenoceptor but not α1-adrenoceptor constriction by
acidosis and hypoxia in vitro. Am J Physiol Heart Circ Physiol
268, H2068–H2076.
Teranishi Y, Tsuru H, Shimomura H, Amano T & Matsubayashi
H (2000). Compensatory vasoconstrictor effects of sodium
pentobarbital on the hindquarters of conscious
normotensive control and lumbar-sympathectomized Wistar
rats. Auton Neurosci 82, 130–136.
Thomas GD, HansenJ&V i c t o rR G(1994). Inhibition of
α2-adrenergic vasoconstriction during contraction of
glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol
Heart Circ Physiol 266, H920–H929.
Thomas GD, HansenJ&V i c t o rR G(1997). ATP-sensitive
potassium channels mediate contraction-induced
attenuation of sympathetic vasoconstriction in rat skeletal
muscle. J Clin Invest 99, 2602–2609.
Tomlinson C, Coney AM & Marshall JM (2005). Do
prostanoids modulate sympathetically-evoked
vasoconstriction in skeletal muscle in normoxia or hypoxia.
FASEB J 19, A713.
Weisbrod CJ, Minson CT, Joyner MJ & Halliwill JR (2001).
Effects of regional phentolamine on hypoxic vasodilatation
in healthy humans. J Physiol 537, 613–621.
Zhao XH, Sun XY, Edvinsson L & Hedner T (1997). Does the
neuropeptide Y Y1-receptor contribute to blood pressure
control in the spontaneously hypertensive rat? JH y p e rt e n s
15, 19–27.
Zukowska-Grojec Z & Vaz AC (1988). Role of neuropeptide Y
(NPY) in cardiovascular responses to stress. Synapse 2,
293–298.
Acknowledgements
This study was generously supported by the British Heart
Foundation.
C   2007 The Authors. Journal compilation C   2007 The Physiological Society